Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2017-05-04 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaktioner af ledende medarbejdere samt disses nærtstående
Director's Dealing Classification · 100% confidence The document is a detailed announcement of share transactions by management and persons closely associated with management, specifically reporting the sale of shares by Novo A/S, closely associated with the CEO and board member. It references compliance with the EU Market Abuse Regulation and provides extensive transaction details including volumes, prices, venues, and timestamps. There is no indication of financial statements, earnings data, or management discussion of financial results. The content is focused on insider trading disclosures, which aligns with the definition of Director's Dealing filings. The document length is substantial and contains detailed transaction data, confirming it is not a brief announcement or a report publication notice. Therefore, the appropriate classification is Director's Dealing (DIRS).
2017-05-04 English
Director's Dealing 2017
Director's Dealing Classification · 99% confidence The document text is very short (356 characters) and is written in Danish. It explicitly references EU Regulation No. 596/2014 (Market Abuse Regulation) and states that Novozymes is hereby publishing the following transactions related to its shares (ISIN DK0060336014). It concludes with a link/instruction to 'Read the entire announcement in PDF format' ('Læs hele meddelelsen i PDF format'). This structure—a brief announcement referencing regulatory compliance and pointing to a full document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content specifically relates to transactions (likely insider trading or major holdings, but the announcement itself is just the publication notice), and given the 'MENU VS MEAL' rule, classifying it as RPA is appropriate if it's announcing the publication of a required disclosure, or RNS as a general regulatory filing. Given the reference to market abuse regulation and publishing transactions, it strongly suggests an insider transaction disclosure (which would normally be DIRS or MRQ), but the text itself is only announcing the publication of that disclosure. Therefore, RPA is the most accurate classification for the announcement wrapper itself.
2017-05-03 Danish
Major Shareholding Notification 2017
Major Shareholding Notification Classification · 99% confidence The document explicitly references 'Regulation (EU) No 596/2014' (Market Abuse Regulation) and details 'transactions' under a specific ISIN and symbol. This structure strongly suggests a mandatory disclosure of insider transactions or transactions by persons discharging managerial responsibilities (PDMRs). The most fitting category among the provided definitions is 'Director's Dealing' (DIRS), which covers personal share transactions by directors and executives (insider trades). Although the text is very short and points to a PDF, the content is specific enough to classify it as DIRS rather than a general RPA or RNS.
2017-05-03 English
Transaktioner af ledende medarbejdere samt disses nærtstående
Director's Dealing Classification · 100% confidence The document is a detailed report of share transactions by a person closely associated with management, specifically Novo A/S related to the CEO and board member of Novozymes A/S. It includes transaction details such as volume, price, venue, and time, complying with EU market abuse regulations. This type of document is a report of personal share transactions by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document is lengthy and contains substantive transaction data, not just an announcement or summary, confirming it is a Director's Dealing report.
2017-05-03 English
Transaktioner af ledende medarbejdere samt disses nærtstående
Director's Dealing Classification · 100% confidence The document is a detailed disclosure of transactions by a person with managerial responsibilities and their close associates, specifically reporting the sale of shares by Novo A/S in Novozymes A/S. It references EU regulation 596/2014 on market abuse and commission regulation 1052/2016, which govern insider trading disclosures. The content includes detailed transaction data such as volume, price, venue, and timestamps. There is no indication of financial statements, earnings data, management discussion, or other report types. The document is not a report publication announcement but a direct disclosure of insider transactions. Therefore, it fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length and detail support a high confidence in this classification.
2017-05-03 English
Director's Dealing 2017
Director's Dealing Classification · 99% confidence The document explicitly references 'Regulation (EU) No 596/2014' (Market Abuse Regulation) and details 'transactions' under a specific ISIN and symbol. This structure strongly suggests a mandatory disclosure of insider transactions or transactions by persons discharging managerial responsibilities (PDMRs). The most fitting category among the provided definitions is 'Director's Dealing' (DIRS), which covers personal share transactions by directors and executives (insider trades). Although the text is very short and points to a PDF, the content is specific enough to classify it as DIRS rather than a general RPA or RNS.
2017-05-02 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.